MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'drug recall'. Sat, 03 Sep 2011 02:50:48 +0100 http://www.medworm.com/index.php?rid=3546848&cid=t_147962_87_f&fid=39187&url=http%3A%2F%2Fgetbetterhealth.com%2Fabout-the-childrens-medication-recall%2F2010.05.08 The [recent] massive recall of some of the most popular [children's] medications is unsettling, disturbing and concerning. Thankfully it was done as a precautionary move before any child was harmed and that there’s a sufficient supply of generic alternatives of the medications recalled. Still, having 40 popular medications recalled by one of today’s most trusted pharmaceutical manufacturers rocks our confidence in the safeguards in place at the core. (more…) *This blog post was originally published at Dr. Gwenn Is In* (Source: Better Health) Better Health blogs http://www.medworm.com/rss/comments.php?id=3546848 Sat, 08 May 2010 18:00:02 +0100 3546848 http://www.medworm.com/index.php?rid=1811490&cid=t_147962_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F397245755%2F Why? Earlier this week, the FDA issued an import alert that allows authorities to stop Ranbaxy drugs and ingredients from entering the US, and issued warning letters for failing to meet manufacturing standards at two plants in India. And the Justice Department alleges Ranbaxy used raw chemicals from unapproved sources, fabricated in-house test data to meet FDA standards and attempted to conceal the ruse from FDA inspectors (back story here and here). Nonetheless, the FDA says its move has nothing do with drugs or active pharmaceuticals ingredients made at Ranbaxy’s other plants, which the FDA has inspected and determined meet requirements for drug manufacturing. In fact, the agency recommends consumers continue taking their existing Ranbaxy meds and “not disrupt their drug ther... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1811490 Fri, 19 Sep 2008 14:17:48 +0100 1811490 http://www.medworm.com/index.php?rid=1478028&cid=t_147962_97_f&fid=35050&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmaGazette%2F%7E3%2F300764497%2Fxiadafil_recalled_by_fda.html The U.S. Food and Drug Administration has issued an immediate recall of all Xiadafil VIP Tabs that were sold in 8 tablet bottles( Lot #6K029) or blister packs of two (Lot #6K029-SEI) due to the fact that they contain a potentially harmful, undeclared ingredient.The undeclared ingredient "may dangerously affect a person's blood pressure and can cause other life-threatening side effects." While Xiadafil is labeled as a dietary supplement that is "all-natural" it is illegally marketed as a drug for the treatment of erectile dysfunction and for sexual enhancement.FDA chemical analysis found that Xiadafil contains an analog of sildenafil, the active ingredient in Viagra that may interact with ingredients in other prescribed medications. It can also have a ... PharmaGazette blogs http://www.medworm.com/rss/comments.php?id=1478028 Thu, 29 May 2008 18:00:40 +0100 1478028 http://www.medworm.com/index.php?rid=1230377&cid=t_147962_97_f&fid=35050&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmaGazette%2F%7E3%2F234617053%2Fduragesic_fentanyl_patches_rec.html Duragesic painkiller patches contain fentanyl have been recalled due to a flaw that could cause patients, or even caregivers, to overdose on the drug.Sold by PriCara in the United States and generically by Sandoz Inc the recall includes all 25-micro-gram-per-hour patches that have an expiry date prior to December 2009.The reason for the recall is that some patches may have a cut in the lining of the internal reservoir, the area where the gel form of the drug is stored, and could leak. Should leaking occur it is possible for the patient or a caregiver come in direct contact with the gel. The result of direct contact could be difficulty breathing and a potentially fatal overdose.The cut in the resevoir is easily seen upon opening and should a cut be detected the patch should be imm... PharmaGazette blogs http://www.medworm.com/rss/comments.php?id=1230377 Wed, 13 Feb 2008 22:30:59 +0100 1230377 http://www.medworm.com/index.php?rid=1204681&cid=t_147962_97_f&fid=35050&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmaGazette%2F%7E3%2F229159965%2Frecalled_heparin_causes_allergic_reaction_in_dialysis_patients.html The Center for Disease Control and Prevention announced that they are investigating 53 incidents of dialysis patients having developed allergic reactions after receiving injections of heparin made by Baxter Healthcare Corp.Last week Baxter voluntarily recalled specific batches of heparin due to reports of adverse events however, the extent of the problem was unknown until the CDC released the information on Friday.The recalled batches have been tested for bacteria and endotoxin but neither was present. "We don't know what the problem is," but heparin remains the leading candidate as the cause, said Dr. Priti Patel, a CDC investigator.To prevent blood clotting during the dialysis process, kidney patients receive heparin and the allergic reaction occured within minutes of ... PharmaGazette blogs http://www.medworm.com/rss/comments.php?id=1204681 Mon, 04 Feb 2008 19:00:50 +0100 1204681 http://www.medworm.com/index.php?rid=1173247&cid=t_147962_97_f&fid=35050&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmaGazette%2F%7E3%2F221906260%2Fphilippines_joins_in_recalling_prexige.html On Friday Philippines health regulators, The Bureau of Food and Drugs, ordered Novartis to "immediately initiate a product recall and cease and desist from further importing, distributing, or selling Lumiracoxib (Prexige)".The Philippines joins Australia, who banned the drug in September and Canada, Great Britain and Germany who recalled the drug in October in the recall of the anti-inflammatory amidst fears that it could cause serious liver related side effects. Prexige never received U.S. FDA approval.The Philippines advisory stated that it had "determined that the risks of Lumiracoxib-containing medicines are greater than their benefits," citing "reports of cases from abroad concerning potential serious liver-related side effects."[... PharmaGazette blogs http://www.medworm.com/rss/comments.php?id=1173247 Wed, 23 Jan 2008 21:00:07 +0100 1173247 http://www.medworm.com/index.php?rid=927913&cid=t_147962_97_f&fid=35050&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmaGazette%2F%7E3%2F165386199%2Fcanada_recalls_prexige_from_market.html Health Canada announced today that it has stopped all sales of Novartis Pharmaceuticals Canada Inc.'s sale of the anti-inflammatory drug, Prexige.The cancellation of market authorization comes due to the risk of liver related illness such as hepatitis. Health Canada based their decision on 4 cases internationally including 2 in Canada.Canada joins Australia, as was previously reported, who pulled approval of the drug in mid-September. Prexige (lumiracoxib), a Cox-3 selective inhibitor non-steroidal anti-inflammatory drug, has been marketed by Novartis (NYSE:NVS) in Canada since November 2006 for adults with symptoms of osteoarthritis. (Source: PharmaGazette) PharmaGazette blogs http://www.medworm.com/rss/comments.php?id=927913 Thu, 04 Oct 2007 21:30:24 +0100 927913 http://www.medworm.com/index.php?rid=885397&cid=t_147962_97_f&fid=35050&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmaGazette%2F%7E3%2F158625219%2Fprexige_recalled_in_australia.html Australia’s Therapeutic Goods Administration (TGA) has ordered the recall of the anti-inflammatory drug Novartis AG’s Prexige. TGA decided on the recall after the medication was linked to two deaths. Claiming to be the first country to issue the recall, the TGA based their decision on a review of eight cases that resulted in severe liver damage. Of the eight cases, two people died and two required liver transplants. "As a result of those case reports we have taken this straight to our drug safety committee who met yesterday," said Rohan Hammett, the TGA's principal medical adviser. Prexige is a non-steroid anti-inflammatory, a Cox-2 inhibitor, in the same class as Vioxx.  Merck voluntarily recalled Vioxx in 2004 due to negative health reactions from patients.... PharmaGazette blogs http://www.medworm.com/rss/comments.php?id=885397 Wed, 19 Sep 2007 17:26:04 +0100 885397